MoneyWorks4Me

The sales surged to Rs. 4252.40 millions, up 25.67% for the September 2023 quarter as against Rs. 3383.70 millions during the corresponding quarter previous year.The Net Loss for the quarter ended September 2023 is Rs. -152.60 millions as compared to Net Loss of Rs. -99.10 millions of corresponding quarter ended September 2022Operating profit surged to 389.00 millions from the corresponding previous quarter of 312.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 4252.40 3383.70 25.67 7775.50 6684.40 16.32 14438.10 12683.40 13.83
Other Income 12.30 37.70 -67.37 33.00 102.50 -67.80 221.40 187.60 18.02
PBIDT 389.00 312.90 24.32 601.10 474.50 26.68 1561.80 991.10 57.58
Interest 244.70 219.60 11.43 499.80 444.60 12.42 900.60 752.70 19.65
PBDT 108.80 93.30 16.61 65.80 29.90 120.07 661.20 203.50 224.91
Depreciation 261.40 285.60 -8.47 519.70 566.10 -8.20 1109.00 1120.10 -0.99
PBT -152.60 -192.30 -20.64 -453.90 -536.20 -15.35 -447.80 -916.60 -51.15
TAX 0.00 -93.20 0.00 -102.50 -245.30 -58.21 -225.70 -331.00 -31.81
Deferred Tax 0.00 -93.20 0.00 -102.50 -245.30 -58.21 -224.60 -331.00 -32.15
PAT -152.60 -99.10 53.99 -351.40 -290.90 20.80 -222.10 -585.60 -62.07
Equity 360.00 360.00 0.00 360.00 360.00 0.00 360.00 360.00 0.00
PBIDTM(%) 9.15 9.25 -1.08 7.73 7.10 8.90 10.82 7.81 38.43
Peers
Company Name CMP
Sun Pharma. Inds. 1849.00
Dr. Reddys Labs. 1198.85
Cipla 1403.85
Lupin 2085.90
Zydus Lifesciences 1196.00
View more..